Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

January

02
2018

Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth

Ships 21 systems including 12 SRT-100 Vision™ systems Conference call…

January

02
2018

Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth

Ships 21 systems including 12 SRT-100 Visionâ„¢ systems Conference call…

January

02
2018

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote…

January

02
2018

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radio Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote…